Cash Flow Statement
Growth Metrics

Mimedx (MDXG) Profit After Tax (2011 - 2026)

Mimedx recorded quarterly Profit After Tax of -$10.9 million in Q1 2026, down 171.49% quarter-over-quarter from $15.2 million in Q4 2025, and down 254.63% year-over-year from $7.0 million in Q1 2025.

Mimedx's Profit After Tax history runs 16 years deep, the most recent figure standing at -$10.9 million for Q1 2026.

  • In Q1 2026, Profit After Tax fell 254.63% year-over-year to -$10.9 million; the TTM figure through Mar 2026 stood at $30.7 million (down 23.19% YoY), while the FY2025 annual figure was $48.6 million, up 15.67% from the prior year.
  • Profit After Tax came in at -$10.9 million for Q1 2026 at Mimedx, down from $15.2 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $62.7 million in Q4 2023 to a low of -$10.9 million in Q2 2022.
  • A 5-year average of $7.1 million and a median of $7.4 million in 2024 frame the typical range for Profit After Tax.
  • Across the five-year window, Profit After Tax sank 510.91% in 2022 and jumped 15242.03% in 2023, its largest moves.
  • Mimedx's Profit After Tax stood at -$414000.0 in 2022, then surged by 15242.03% to $62.7 million in 2023, then tumbled by 88.13% to $7.4 million in 2024, then soared by 104.24% to $15.2 million in 2025, then tumbled by 171.49% to -$10.9 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$10.9 million, $15.2 million, and $16.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -2.99 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 30.90 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14.46 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.03 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -3.63 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 727.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 205.99 Mn
10 Mimedx 530.69 Mn 370.92 Mn 41.62 Mn -10.86 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -10.86 Mn
Dec 31, 2025 15.19 Mn
Sep 30, 2025 16.75 Mn
Jun 30, 2025 9.62 Mn
Mar 31, 2025 7.02 Mn
Dec 31, 2024 7.44 Mn
Sep 30, 2024 7.88 Mn
Jun 30, 2024 17.63 Mn
Mar 31, 2024 9.26 Mn
Dec 31, 2023 62.69 Mn
Sep 30, 2023 8.53 Mn
Jun 30, 2023 1.20 Mn
Mar 31, 2023 -1.94 Mn
Dec 31, 2022 -414,000.00
Sep 30, 2022 -8.43 Mn
Jun 30, 2022 -10.87 Mn
Mar 31, 2022 -10.49 Mn
Dec 31, 2021 199,000.00
Sep 30, 2021 -2.34 Mn
Jun 30, 2021 -1.78 Mn
Mar 31, 2021 -8.38 Mn
Dec 31, 2020 -16.58 Mn
Sep 30, 2020 -19.42 Mn
Jun 30, 2020 -8.47 Mn
Mar 31, 2020 -4.82 Mn
Dec 31, 2019 -7.48 Mn
Sep 30, 2019 12.38 Mn
Jun 30, 2019 -17.21 Mn
Mar 31, 2019 -13.27 Mn
Dec 31, 2018 -36.22 Mn
Sep 30, 2018 -178,000.00
Jun 30, 2018 1.80 Mn
Mar 31, 2018 4.62 Mn
Dec 31, 2017 4.28 Mn
Sep 30, 2017 44.05 Mn
Jun 30, 2017 10.40 Mn
Mar 31, 2017 6.00 Mn
Dec 31, 2016 5.48 Mn
Sep 30, 2016 3.32 Mn
Jun 30, 2016 1.98 Mn
Mar 31, 2016 1.20 Mn
Dec 31, 2015 13.38 Mn
Sep 30, 2015 6.55 Mn
Jun 30, 2015 5.43 Mn
Mar 31, 2015 4.09 Mn
Dec 31, 2014 3.83 Mn
Sep 30, 2014 3.70 Mn
Jun 30, 2014 -390,000.00
Mar 31, 2014 -922,000.00
Dec 31, 2013 -1.43 Mn
Sep 30, 2013 -307,000.00
Jun 30, 2013 -757,000.00
Mar 31, 2013 -1.62 Mn
Dec 31, 2012 -1.61 Mn
Sep 30, 2012 -4.22 Mn
Jun 30, 2012 -744,000.00
Mar 31, 2012 -1.09 Mn
Dec 31, 2011 -2.58 Mn
Sep 30, 2011 -1.77 Mn
Jun 30, 2011 -2.50 Mn
Mar 31, 2011 -3.35 Mn